论文部分内容阅读
本刊综合消息:人民日报、北京日报、云南日报1983年11月底报道,我国对抗癌新药顺铂的应用研究,在合成方法、质量标准、基础试验等方面取得重要进展。从两年多来完成的660多例临床试验表明,单用顺铂治疗晚期癌症,缓解率达30%左右,用顺铂配合钴~(60)放射治疗,对晚期癌症的缓解率可达70%左右。这一科研成果于1983年9月底在昆明通过鉴定,经有关部门批准后,将投放市场。
The comprehensive news: People’s Daily, Beijing Daily, Yunnan Daily reported in late November 1983 reported on the application of anti-cancer drug cisplatin in China, the synthesis methods, quality standards, basic tests and achieved significant progress. More than 660 clinical trials completed in more than two years show that with cisplatin in the treatment of advanced cancer, the remission rate is about 30%. With cisplatin and cobalt 60 radiation therapy, the remission rate of advanced cancer can reach 70 %about. This scientific research achievement passed the appraisal in Kunming at the end of September, 1983, and will be put on the market after being approved by relevant departments.